Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

Cited In for PubMed (Select 17327408)

1.

A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival.

Baecklund F, Foo JN, Bracci P, Darabi H, Karlsson R, Hjalgrim H, Rosenquist R, Adami HO, Glimelius B, Melbye M, Conde L, Liu J, Humphreys K, Skibola CF, Smedby KE.

BMC Med Genet. 2014 Oct 8;15(1):113. doi: 10.1186/s12881-014-0113-6.

2.

The associations between immunity-related genes and breast cancer prognosis in Korean women.

Choi J, Song N, Han S, Chung S, Sung H, Lee JY, Jung S, Park SK, Yoo KY, Han W, Lee JW, Noh DY, Kang D, Choi JY.

PLoS One. 2014 Jul 30;9(7):e103593. doi: 10.1371/journal.pone.0103593. eCollection 2014.

3.

Active idiotypic vaccination versus control immunotherapy for follicular lymphoma.

Levy R, Ganjoo KN, Leonard JP, Vose JM, Flinn IW, Ambinder RF, Connors JM, Berinstein NL, Belch AR, Bartlett NL, Nichols C, Emmanouilides CE, Timmerman JM, Gregory SA, Link BK, Inwards DJ, Freedman AS, Matous JV, Robertson MJ, Kunkel LA, Ingolia DE, Gentles AJ, Liu CL, Tibshirani R, Alizadeh AA, Denney DW Jr.

J Clin Oncol. 2014 Jun 10;32(17):1797-803. doi: 10.1200/JCO.2012.43.9273. Epub 2014 May 5.

PMID:
24799467
4.

Nature and importance of follicular lymphoma precursors.

Mamessier E, Broussais-Guillaumot F, Chetaille B, Bouabdallah R, Xerri L, Jaffe ES, Nadel B.

Haematologica. 2014 May;99(5):802-10. doi: 10.3324/haematol.2013.085548. Review.

5.

Genetic Variations of Tumor Necrosis Factor -α-308 and Lymphtoxin-α+252 in Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Patients.

Nasiri H, Farajnia S, Rezamand A, Movassaghpour AA, Esmaeili HA, Monfaredan A, Mobarra N, Rahimifar N, Sahebi L, Farshdousti Hagh M.

Iran J Basic Med Sci. 2013 Sep;16(9):990-5.

6.

Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohorts.

Ghesquières H, Maurer MJ, Casasnovas O, Ansell SM, Larrabee BR, Lech-Maranda E, Novak AJ, Borrel AL, Slager SL, Brice P, Allmer C, Brion A, Ziesmer SC, Morschhauser F, Habermann TM, Gaillard I, Link BK, Stamatoullas A, Fermé C, Dogan A, Macon WR, Audouin J, Cerhan JR, Salles G.

Cytokine. 2013 Nov;64(2):523-31. doi: 10.1016/j.cyto.2013.08.002. Epub 2013 Sep 3.

7.

Survival prediction based on inherited gene variation analysis.

Cicek MS, Maurer MJ, Goode EL.

Methods Mol Biol. 2013;1049:53-64. doi: 10.1007/978-1-62703-547-7_5.

8.

Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research.

Elena JW, Travis LB, Simonds NI, Ambrosone CB, Ballard-Barbash R, Bhatia S, Cerhan JR, Hartge P, Heist RS, Kushi LH, Lash TL, Morton LM, Onel K, Pierce JP, Robison LL, Rowland JH, Schrag D, Sellers TA, Seminara D, Shu XO, Thomas NE, Ulrich CM, Freedman AN.

J Natl Cancer Inst. 2013 Jan 16;105(2):85-94. doi: 10.1093/jnci/djs473. Epub 2012 Nov 28. Review.

9.

Risk Factors of Follicular Lymphoma.

Ma S.

Expert Opin Med Diagn. 2012 Jul 1;6(4):323-333. Epub 2012 May 8.

10.

Inherited genetic variation and overall survival following follicular lymphoma.

Gibson TM, Wang SS, Cerhan JR, Maurer MJ, Hartge P, Habermann TM, Davis S, Cozen W, Lynch CF, Severson RK, Rothman N, Chanock SJ, Morton LM.

Am J Hematol. 2012 Jul;87(7):724-6. doi: 10.1002/ajh.23184. Epub 2012 Mar 31.

11.

Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.

Lu Y, Abdou AM, Cerhan JR, Morton LM, Severson RK, Davis S, Cozen W, Rothman N, Bernstein L, Chanock S, Hartge P, Wang SS.

ScientificWorldJournal. 2011;11:2062-70. doi: 10.1100/2011/373876. Epub 2011 Nov 1.

12.

Polymorphisms in immune function genes and non-Hodgkin lymphoma survival.

Aschebrook-Kilfoy B, Zheng T, Foss F, Ma S, Han X, Lan Q, Holford T, Chen Y, Leaderer B, Rothman N, Zhang Y.

J Cancer Surviv. 2012 Mar;6(1):102-14. doi: 10.1007/s11764-010-0164-4. Epub 2011 Nov 24.

13.

Risk Factors of Non-Hodgkin Lymphoma.

Zhang Y, Dai Y, Zheng T, Ma S.

Expert Opin Med Diagn. 2011 Nov 1;5(6):539-550.

14.

Host genetics in follicular lymphoma.

Cerhan JR.

Best Pract Res Clin Haematol. 2011 Jun;24(2):121-34. doi: 10.1016/j.beha.2011.02.004. Epub 2011 May 5. Review.

15.

Identification of predictive pathways for non-hodgkin lymphoma prognosis.

Han X, Li Y, Huang J, Zhang Y, Holford T, Lan Q, Rothman N, Zheng T, Kosorok MR, Ma S.

Cancer Inform. 2010 Dec 7;9:281-92. doi: 10.4137/CIN.S6315.

16.

SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma.

Wrench D, Leighton P, Skibola CF, Conde L, Cazier JB, Matthews J, Iqbal S, Carlotti E, Bödör C, Montoto S, Calaminici M, Gribben JG, Lister TA, Fitzgibbon J.

Blood. 2011 Mar 17;117(11):3147-50. doi: 10.1182/blood-2010-10-315382. Epub 2011 Jan 13.

17.

Bayesian ensemble methods for survival prediction in gene expression data.

Bonato V, Baladandayuthapani V, Broom BM, Sulman EP, Aldape KD, Do KA.

Bioinformatics. 2011 Feb 1;27(3):359-67. doi: 10.1093/bioinformatics/btq660. Epub 2010 Dec 8.

18.

Recent advances in the treatment of B-cell lymphoma.

Habermann TM.

F1000 Med Rep. 2009 Feb 24;1. pii: 13. doi: 10.3410/M1-13.

19.

Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study.

Geyer SM, Morton LM, Habermann TM, Allmer C, Davis S, Cozen W, Severson RK, Lynch CF, Wang SS, Maurer MJ, Hartge P, Cerhan JR.

Cancer. 2010 Jun 15;116(12):2993-3000. doi: 10.1002/cncr.25114.

20.

Inherited determinants of ovarian cancer survival.

Goode EL, Maurer MJ, Sellers TA, Phelan CM, Kalli KR, Fridley BL, Vierkant RA, Armasu SM, White KL, Keeney GL, Cliby WA, Rider DN, Kelemen LE, Jones MB, Peethambaram PP, Lancaster JM, Olson JE, Schildkraut JM, Cunningham JM, Hartmann LC.

Clin Cancer Res. 2010 Feb 1;16(3):995-1007. doi: 10.1158/1078-0432.CCR-09-2553. Epub 2010 Jan 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk